Consistency of Automated Neuropsychological Assessment Metrics (ANAM) Performance in Those With Deployment Acquired Mild Traumatic Brain Injury (TBI)

Completed

Conditions studied: Mild Traumatic Brain Injury, Post-Concussive Symptoms

In brief

The purpose of this project is to explore the degree to which performance consistency on neuropsychological measures varies in a sample of Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans with a history of mild traumatic brain injury (mTBI) with persistent self-reported symptoms.

Key facts

Study ID

NCT01334528

Run by

VA Eastern Colorado Health Care System

People needed

3

Starts

2011-02-01

Expected to finish

2016-01-01

Last updated by the study team

2016-01-15

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Between the ages of 18-45 years old
• At least one OEF/OIF deployment
• Currently receiving physical and/or mental health care through the VA Eastern Colorado Health Care System
• For TBI group - veteran must have a history of at least one deployment- related mild TBI with persistent symptoms

You may not qualify if…

• Effortful performance on the Test of Memory Malingering (TOMM)
• History of other significant neurological disease (other than mild TBI for the appropriate group) as assessed by interview and chart review
• History or diagnosis of deployment-related moderate or severe TBI or mild TBI without persistent symptoms for the TBI groups, or any history of deployment-related TBI for the non-TBI group, as assessed by interview and chart review
• History or diagnosis of non-deployment-related TBI
• Diagnosis of Schizophrenia or Bipolar Mood DisorderI Disorder as assessed by interview and/or chart review.
• Problematic drinking behavior that consistently exceeds recommended drinking limits per day, e.g., Diagnosis of Alcohol Abuse Disorder or Alcohol Dependence Disorder per the MINI; or five or more alcoholic drinks per day, four out of seven days per week for the previous two weeks or during the assessment process
• Use of illicit substance(s) more than five times in the two weeks before enrollment or during the testing process.
• Inability to read the informed consent document or adequately respond to questions regarding the informed consent procedure

Where it is running

• Eastern Colorado Health Sciences Denver VA MIRECC — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.